StockData
InflaRx N.V. logo

InflaRx N.V. (IFRX) income statement

IFRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 20, 2026Score 5/30
$1.11−0.04 (-3.48%)

Close on Nov 18, 2026Market cap $80.25MP/E –Yield –

InflaRx N.V. income statement

Ratios

Latest available, balances at Dec 31, 2025

Profitability, FY2025

Gross margin
-24677.9%
Operating margin
–
Net margin
–
Return on equity, FY2025
–

Financial strength

Current ratio
4.13
Debt to equity
–
Debt to assets
–
Cash to current liabilities
123.4%

Valuation

P/E ratio
–
Price to sales
2479.47
Price to book
10.14
Dividend yield
–

See a number that looks wrong?